Duncan D. McCulloch’s holdings in IDEXX Laboratories (IDXX) are substantial, reflecting his commitment to the company. In recent years, his wealth tied to IDEXX stock has shown impressive growth, especially between 2020 and 2023 where the value of his stock...

$25.33M-12.44%

Sep 12, 2024

Recent Insider Trades

No insider trades found for this CEO.

Duncan D. McCulloch

CEO of Idexx Laboratories

I

View Compensation History

2022 Total Compensation

$11.52M

Salary

$1.00M

Bonus

$1.74M

Stock

$8.75M

Other

$31.27K